scispace - formally typeset
A

A. van Tol

Researcher at Erasmus University Rotterdam

Publications -  129
Citations -  6337

A. van Tol is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Cholesterol & Lipoprotein. The author has an hindex of 42, co-authored 129 publications receiving 6193 citations. Previous affiliations of A. van Tol include Katholieke Universiteit Leuven.

Papers
More filters
Journal ArticleDOI

Association between valgus and varus alignment and the development and progression of radiographic osteoarthritis of the knee.

TL;DR: An increasing degree of varus alignment is associated not only with progression of knee OA but also with development of knees OA, however, this association seems particularly applicable to overweight and obese persons.
Journal ArticleDOI

Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.

TL;DR: The data indicate that the clearance of postprandial lipoproteins in normolipidemic CAD patients as selected in the present study is delayed as compared with that of controls without coronary atherosclerosis and suggest that postpr andial lipiproteins may play a role in the etiology of their disease.
Journal ArticleDOI

Human plasma phospholipid transfer protein causes high density lipoprotein conversion.

TL;DR: It is demonstrated that PLTP can act like the putative conversion factor and has the ability to convert HDL3 into populations of larger and smaller HDL particles.
Journal ArticleDOI

On the metabolic function of heparin-releasable liver lipase.

TL;DR: The results suggest that liver Lipase may promote phospholipid removal in vivo and show that a lowering of liver lipase in situ has profound consequences for serum lipoprotein metabolism.
Journal ArticleDOI

Daily moderate alcohol consumption increases serum paraoxonase activity : a diet-controlled, randomised intervention study in middle-aged men

TL;DR: The data suggest that increased serum paraoxonase may be one of the biological mechanisms underlying the reduced coronary heart disease risk in moderate alcohol consumers, and is strongly correlated with coincident increases in concentrations of HDL-C and apo A-I.